Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein

被引:68
作者
Rhee, EJ
Lee, WY [1 ]
Kim, SY
Kim, BJ
Sung, KC
Kim, BS
Kang, JH
Oh, KW
Oh, ES
Baek, KH
Kang, MI
Woo, HY
Park, HS
Kim, SW
Lee, MH
Park, JR
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul 110746, South Korea
[2] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Res Inst Med Sci, Sch Med, Seoul 110746, South Korea
[3] Hallym Univ, Dept Internal Med, Coll Med, Anyang 431070, Pyungchon, South Korea
[4] Miz Medi Hosp, Dept Internal Med, Seoul 157280, South Korea
[5] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul 137701, South Korea
[6] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Lab Med, Sch Med, Seoul 110746, South Korea
关键词
atherosclerosis; coronary artery disease; C-reactive protein (CRP); left ventricular mass index; osteoprotegerin;
D O I
10.1042/CS20040255
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
OPG (osteoprotegerin) is an inhibitor of osteoclastogenesis and recent work suggests it has a role in atherosclerosis. Therefore we measured serum OPG levels in patients with coronary artery disease, compared the serum OPG levels among the different groups according to the number of stenotic vessels and determined whether there was any correlation with aortic calcification, LV (left ventricular) mass index and serum CRP (C-reactive protein) levels. Subjects (n = 100; mean age, 57 years) who underwent coronary angiograms were enrolled. Blood pressure, body mass index, fasting blood glucose, lipid profiles and CRIP levels were measured and the LV mass indices were calculated using ECGs. Serum OPG levels were measured by ELISA. The presence of calcification in the aortic notch was checked by a chest X-ray. The subjects were divided into four groups according to the number of stenotic vessels. The mean serum OPG levels increased significantly as the number of stenotic vessels increased, and the mean serum OPG levels were higher in the group with three-vessel disease compared with the groups with no- or one-vessel disease. The mean serum CRP level was significantly higher in the group with three-vessel disease compared with the groups with no-, one- and two-vessel disease. Age and LV mass index showed significant positive correlations with serum OPG levels, although significance was lost after an adjustment for age. Serum CRP levels were positively correlated with serum OPG levels even after an adjustment for age. There were no differences in serum OPG levels according to the presence of fasting hyperglycaemia or aortic calcification. In conclusion, serum OPG level was related to the severity of stenotic coronary arteries and serum CRP levels. LV mass indices showed no significant correlation with OPG levels. The precise mechanism for the role of OPG in atherosclerosis needs to be investigated further.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 33 条
  • [1] Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women
    Browner, WS
    Lui, LY
    Cummings, SR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) : 631 - 637
  • [2] osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
    Bucay, N
    Sarosi, I
    Dunstan, CR
    Morony, S
    Tarpley, J
    Capparelli, C
    Scully, S
    Tan, HL
    Xu, WL
    Lacey, DL
    Boyle, WJ
    Simonet, WS
    [J]. GENES & DEVELOPMENT, 1998, 12 (09) : 1260 - 1268
  • [3] ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD
    DEVEREUX, RB
    REICHEK, N
    [J]. CIRCULATION, 1977, 55 (04) : 613 - 618
  • [4] Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques
    Dhore, CR
    Cleutjens, JPM
    Lutgens, E
    Cleutjens, KBJM
    Geusens, PPM
    Kitslaar, PJEHM
    Tordoir, JHM
    Spronk, HMH
    Vermeer, C
    Daemen, MJAP
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (12) : 1998 - 2003
  • [5] Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
    Emery, JG
    McDonnell, P
    Burke, MB
    Deen, KC
    Lyn, S
    Silverman, C
    Dul, E
    Appelbaum, ER
    Eichman, C
    DiPrinzio, R
    Dodds, RA
    James, IE
    Rosenberg, M
    Lee, JC
    Young, PR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) : 14363 - 14367
  • [6] POTENTIAL MECHANISMS EXPLAINING THE RISK OF LEFT-VENTRICULAR HYPERTROPHY
    FROHLICH, ED
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (02) : A91 - A97
  • [7] Progression of aortic calcification is associated with metacarpal bone loss during menopause - A population-based longitudinal study
    Hak, AE
    Pols, HAP
    van Hemert, AM
    Hofman, A
    Witteman, JCM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (08) : 1926 - 1931
  • [8] Role of low levels of endogenous estrogen in regulation of bone resorption in late postmenopausal women
    Heshmati, HM
    Khosla, S
    Robins, SP
    O'Fallon, WM
    Melton, LJ
    Riggs, BL
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (01) : 172 - 178
  • [9] Osteoprotegerin: a link between osteoporosis and arterial calcification?
    Hofbauer, LC
    Schoppet, M
    [J]. LANCET, 2001, 358 (9278) : 257 - 259
  • [10] Effects of immunosuppressants on receptor activator of NF-κB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
    Hofbauer, LC
    Shui, CX
    Riggs, BL
    Dunstan, CR
    Spelsberg, TC
    O'Brien, T
    Khosla, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (01) : 334 - 339